Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. (Q34554455)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

M Tanner

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

T T Junttila

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A I Kapanen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S Tommola

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Y Soini

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

H Helin

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Salo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

H Joensuu

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

E Sihvo

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Isola

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 February 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

273-278

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Targeting HER2 in other tumor types

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

The HER-2/neu oncogene in tumors of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Mutations of the human E-cadherin (CDH1) gene.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Analysis of 154 actual five-year survivors of gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Identifiers

10.1093/ANNONC/MDI064

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34554455&oldid=1636955395"